BMJ: How much do you know about the Covaxin vaccine in India: Hastily launched, controversy continues

India quickly approved and launched its own Covaxin vaccine.

Covaxin was developed by the Indian pharmaceutical company Bharat Biotech in cooperation with the Indian Medical Research Council (a government-funded biomedical research institution) and its affiliated institution, the National Institute of Virology.

The vaccine is similar to the coronavirus vaccine (a vaccine developed in China) in that it uses a complete infectious SARS-CoV-2 virus particle, composed of RNA, surrounded by a protein shell, but modified So that it cannot be copied.

immunity

Why did India choose to develop its own vaccine?

With the goal of vaccinating 300 million people every quarter, costs are rising.

The Central Committee on Medicines and Standards (CDSCO), India's highest drug regulatory agency , urgently approved Covaxin on January 3, 2021.

Covaxin was urgently approved on January 3, 2021, although the Phase III clinical trial of Covaxin is still in progress, and the phase II study has not yet been published .

The emergency approval before the completion of the third phase of the experiment has aroused widespread criticism from the Indian scientific community .

In the third stage of emergency approved before completion of the test sparked widespread criticism of the Indian scientific community for urgent ratification before the completion of the third phase of the trial led to widespread criticism from the scientific community in India infected hasty hasty shocked "and" confused shocked "and" Confused that the criticism of Covaxin is "irresponsible" The criticism of Covaxin is "irresponsible"

Original source

What do we know about India's Covaxin vaccine? BMJ 2021; 373 doi: https://doi.

What do we know about India's Covaxin vaccine? BMJ 2021; 373 doi: https://doi.

Leave a message here